Medication info
Glipizide 4 mg Tablet (Glimepiride)

Glipizide 4 mg Tablet (Glimepiride)

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›4mg / 1 tablet
Manufacturer / importer
IQURE Co., Ltd.
Appearance
Light blue, oblong tablet
Packaging
For domestic use - 30 tablets/bottle, For domestic use - 500 tablets/bottle
Approval status
Active

MFDS item code 202002784 · Approved 2020.04.21 · Insurance code 674402210

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 glass of water. This medicine is administered orally once daily. It should be taken before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, start treatment with 1 mg of glimepiride once daily. If needed, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, there is little additional benefit at doses above 4 mg, although some patients have achieved better metabolic control with an increase to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control improves during treatment, the need for this medicine may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered in the event of weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia. 3) Switching from another oral hypoglycemic agent to this medicine There is no exact dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is advisable to follow the method described under Initial dose. That is, start with 1 mg once daily and adjust the dose at 1 ~ 2-week intervals. The potency and duration of action of the previously administered medicine should be taken into consideration. 4) Dose adjustment during treatment Blood glucose and/or urine glucose levels should be measured regularly while taking this medicine; regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia can be promptly controlled by immediately consuming sugar. Hypoglycemia may recur even after it has been successfully managed initially during treatment with a sulfonylurea. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and start insulin at a low dose, increasing it at approximately weekly intervals according to fasting blood glucose measurements. Once stabilized, monitor capillary blood glucose daily whenever possible. Insulin dose adjustment at regular intervals is necessary while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, adding metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level can be achieved by adjusting the dose of each medicine. However, efforts should be made to identify the minimum effective dose of each medicine for glycemic control. There is a risk of hypoglycemia when this medicine is coadministered with metformin, and the risk may increase. Appropriate precautions should be taken.

Ingredients

Manufacturer
IQURE Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Abnormal blood sugar control in patients with type 2 diabetes
View approved original text

This medication is used to assist dietary and exercise therapy to help control blood sugar levels in patients with type 2 diabetes. It can be administered alone or in combination with insulin if adequate blood sugar control is difficult with oral hypoglycemic agents. Additionally, it can be used in combination with metformin if blood sugar control is not effective with sulfonylureas or metformin alone. This medication effectively improves blood sugar levels, aiding in diabetes management.

How to take

Adult dose

Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 glass of water. This medicine is administered orally once daily. It should be taken before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, start treatment with 1 mg of glimepiride once daily. If needed, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, there is little additional benefit at doses above 4 mg, although some patients have achieved better metabolic control with an increase to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control improves during treatment, the need for this medicine may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered in the event of weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia. 3) Switching from another oral hypoglycemic agent to this medicine There is no exact dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is advisable to follow the method described under Initial dose. That is, start with 1 mg once daily and adjust the dose at 1 ~ 2-week intervals. The potency and duration of action of the previously administered medicine should be taken into consideration. 4) Dose adjustment during treatment Blood glucose and/or urine glucose levels should be measured regularly while taking this medicine; regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia can be promptly controlled by immediately consuming sugar. Hypoglycemia may recur even after it has been successfully managed initially during treatment with a sulfonylurea. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and start insulin at a low dose, increasing it at approximately weekly intervals according to fasting blood glucose measurements. Once stabilized, monitor capillary blood glucose daily whenever possible. Insulin dose adjustment at regular intervals is necessary while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, adding metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level can be achieved by adjusting the dose of each medicine. However, efforts should be made to identify the minimum effective dose of each medicine for glycemic control. There is a risk of hypoglycemia when this medicine is coadministered with metformin, and the risk may increase. Appropriate precautions should be taken.

Precautions

This medication should not be administered to patients with insulin-dependent diabetes mellitus, diabetic ketoacidosis, or those in a coma. Patients with allergies to this medication or its ingredients, or to sulfonylureas or sulfonamides should not use it. Patients with severely impaired liver or kidney function should avoid this medication and consider switching to insulin therapy. Women who are pregnant or may become pregnant, as well as those who are breastfeeding, should not take this medication. Patients with severe infections, pre- and post-surgery, or with major trauma should also consider insulin therapy. In cases of gastrointestinal disorders such as diarrhea or vomiting, nutritional absorption may be impaired, increasing the risk of hypoglycemia. During the first week of taking this medication, the risk of hypoglycemia is higher, so frequent blood glucose monitoring and careful observation is essential. Particularly, patients with poor nutritional status, those who skip meals, irregular eating patterns, excessive exercise, unbalanced carbohydrate intake, alcohol consumers, patients with impaired kidney or liver function, and the elderly are at greater risk of hypoglycemia and should be administered this medication carefully. Overdosing may lead to hypoglycemia; therefore, dosage must be strictly followed, and if hypoglycemic symptoms appear, glucose should be consumed immediately. Hypoglycemia symptoms may include headache, severe hunger, nausea, fatigue, drowsiness, confusion, shaking, dizziness, etc., so caution is advised. This medication can cause various side effects such as liver dysfunction, blood disorders, allergic reactions, and any unusual symptoms should be reported to a doctor or pharmacist immediately. Moreover, interactions may occur when taken with other medications, so inform healthcare professionals about any concurrent medications. During the course of taking this medication, maintaining a regular diet, exercise, and weight management is essential, and continuous monitoring of blood sugar levels is necessary. There is a risk of accidents due to hypoglycemia when driving or operating machinery, so caution is advised if symptoms occur. Pregnant or nursing women should not use this medication and must consider switching to insulin therapy if needed, as safety has not been established for children under 18 years of age. Elderly patients often have decreased kidney function, so dosage adjustments should be considered, and in case of overdose, they should quickly seek appropriate medical treatment.

Side effects

Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disorders, anxiety, aggression, decreased concentration, decreased agility or drive, depression, confusion, speech abnormalities, aphasia, visual impairment, tremors, incomplete paralysis, sensory disturbances, dizziness, weakness, loss of self-control, transient mental confusion, seizures, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cool and moist skin, tachycardia, hypertension, palpitations, angina, deep vein thrombosis, blurred vision, fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, bile secretion disorders, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, eosinopenia, agranulocytosis, pancytopenia, itching, urticaria, rash, shortness of breath, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photosensitivity reactions of the skin, decreased serum sodium concentration, taste disturbances, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, arthralgia, dyspepsia, facial swelling, erectile dysfunction, flushing of the face, gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air or moisture from entering, ideally at room temperature between 1°C and 30°C. Proper storage will help maintain the medication's effectiveness and safety.

Appearance and packaging

Appearance

Light blue, oblong tablet

Package unit

For domestic use - 30 tablets/bottle, For domestic use - 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.